Central America Pharmaceuticals & Healthcare Report Q4 2012 - New Market Research Report
BMI View: Uninitiated pharmaceutical firms and medical device companies will find Central America a challenging, but ultimately rewarding proposition. Industrial action is common, procurement is inefficient and healthcare policy implementation is often delayed. Positive aspects include increasing government commitment to the provision of medical services, improving regulations and increasing investment by multinational firms.
View full press release